Back to trial details

Intake questionnaire

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

Applying to OSF Healthcare System; Saint Francis Medical Center · Peoria, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Non Small Cell Lung Cancer?
3. Are you able to travel to Peoria for study visits?